Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Aberdeen University scientists discover cancer-fighting compound in Africa

Dr Deng , Dr Kwaku Kyeremeh and Professor Marcel Jaspars
Dr Deng , Dr Kwaku Kyeremeh and Professor Marcel Jaspars

Researchers at a north-east university believe they could have found the compounds for a new cancer-busting drug – buried deep in the heart of Africa.

An international research team led by Aberdeen University, Wuhan University in China and Ghana University has discovered important new mixes of elements found in Ghanaian soil.

Scientists have now identified for the first time the compound legonmycins – which they named after the region in the west African nation in which it was found – and believe it could be used to develop new drugs to fight cancer.

It belongs to a group of naturally occurring chemical compounds, which are similar to those used as anti-tumour agents and anti-flammatories. However, until now their origins has been poorly misunderstood, making it harder to develop drugs.

Now the Aberdeen-led research team has taken an important step forward in establishing how and why these compounds occur.

Dr Hai Deng, from Aberdeen University, described their work – which is published in the top international journal Angewandte Chemie Int. Ed – as “a breakthrough”.

He said: “We have made a breakthrough in understanding this with the compound we discovered called legonmycins and this has implications for our understanding of other bacterium-derived compounds within this family which are known to have cancer-fighting properties.”

Dr Deng said the next stage would be to look at how the compound ‘code’ they have unravelled in legonmycins can be applied more widely to help treat cancer.

He added: “We have been able to pin point how one particular protein acts as a catalyst to make things happen within the molecules of legonmycins.

“Now we have an understanding of this, we will look to synthesise the process in our laboratories. Once we can do that it opens up the potential to create many other analogues using synthetic biology.

“This is the ultimate goal for this type of research and our current findings are an important step forward in achieving that aim.”